New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cabot Corporation
CBT
Shape
US Flag

NYSE

6B

Chemicals - Specialty

Next Earning date - 03 Feb 2025

6B

Chemicals - Specialty

Next Earning date - 03 Feb 2025

109.50USD
Shape-1.09 ( -0.99%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

5%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated November 28, 2024
1W -0.78 % 1M 0.58 % 3M 5.46 % 1Y 47.87 %

Key Metrics

Shape
  • Market Cap

    5.96B


  • Shares Outstanding

    54.39M


  • Share in Float

    53.57M


  • Dividende

    1.26


  • Earning Date

    03 Feb 2025


  • Price Target

    109.5


  • Average Volume

    368793


  • Beta

    1.189


  • Range

    70.63-117.46


  • Industry

    Chemicals - Specialty


  • Website

    https://www.cabotcorp.com


  • Sector

    Basic Materials


Fundamentals

Shape

15.51x

P/E Ratio

1.49x

P/S Ratio

4.33x

P/B Ratio

0.8

Debt/Equity

9.5%

Net Margin

$6.7

EPS

How CBT compares to sector?

P/E Ratio

Relative Strength

Shape

CBT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape317%

2025-Revenue

$7.65

Shape215%

2025-EPS

$682M

Shape257%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Canaccord Genuity

downgrade

Previous: Not converted

2022-11-16

Now: Hold

Deutsche Bank

downgrade

Previous: Buy

2022-11-16

Now: Hold

Goldman Sachs

downgrade

Previous: Not converted

2022-11-16

Now: Neutral

Evercore ISI

initialise

Previous: Not converted

2022-11-16

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-24%

0.98
vs 1.29

Q1.23

arrow
arrow

-21%

1.33
vs 1.69

Q2.23

arrow
arrow

-18%

1.42
vs 1.73

Q3.23

arrow
arrow

+6%

1.65
vs 1.55

Q4.23

arrow
arrow

+59%

1.56
vs 0.98

Q1.24

arrow
arrow

+34%

1.78
vs 1.33

Q2.24

arrow
arrow

+35%

1.92
vs 1.42

Q3.24

arrow
arrow

+9%

1.8
vs 1.65

Q4.24

arrow
arrow

+12%

1.74
vs 1.56

Q1.25

arrow
arrow

+6%

1.89
vs 1.78

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

0%

965M  vs 968M

Q1.23

arrow
arrow

-5%

1B  vs 1.1B

Q2.23

arrow
arrow

-16%

968M  vs 1.1B

Q3.23

arrow
arrow

-13%

965M  vs 1.1B

Q4.23

arrow
arrow

-1%

958M  vs 965M

Q1.24

arrow
arrow

-1%

1B  vs 1B

Q2.24

arrow
arrow

+5%

1B  vs 968M

Q3.24

arrow
arrow

+4%

1B  vs 965M

Q4.24

arrow
arrow

+4%

995.4M  vs 958M

Q1.25

arrow
arrow

+4%

1.1B  vs 1B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+5%

0.05
vs 0.1

Q1.23

arrow
arrow

+7%

0.07
vs 0.05

Q2.23

arrow
arrow

+7%

0.07
vs 0.07

Q3.23

arrow
arrow

+19%

0.19
vs 0.07

Q4.23

arrow
arrow

+4%

0.04
vs 0.19

Q1.24

arrow
arrow

+6%

0.06
vs 0.04

Q2.24

arrow
arrow

+8%

0.08
vs 0.06

Q3.24

arrow
arrow

+10%

0.1
vs 0.08

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

323

323
vs 310

4%

Q1.23

arrow
arrow

311

311
vs 323

-4%

Q2.23

arrow
arrow

289

289
vs 311

-7%

Q3.23

arrow
arrow

300

300
vs 289

4%

Q4.23

arrow
arrow

338

338
vs 300

13%

Q1.24

arrow
arrow

365

365
vs 338

8%

Q2.24

arrow
arrow

392

392
vs 365

7%

Q3.24

arrow
arrow

406

406
vs 392

4%

Earnings Growth

Latest News

CBT

businesswire.com

17 hours ago